Literature DB >> 2114953

Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.

T T Rubio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2114953     DOI： 10.1016/0732-8893(90)90099-h

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


× No keyword cloud information.
  6 in total

Review 1.  Cystic fibrosis--an Indian perspective on recent advances in diagnosis and management.

Authors:  S K Kabra; M Kabra; M Ghosh; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

Review 2.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 4.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 5.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

6.  Antibiotic prophylaxis in the management of vesicoureteral reflux.

Authors:  Marc Cendron
Journal:  Adv Urol       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.